Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-03-06 @ 1:13 PM
Study NCT ID:
NCT02115594
Status:
WITHDRAWN
Last Update Posted:
2014-10-08
First Post:
2014-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer
Sponsor:
Syndax Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04
Start Date Type:
None
Primary Completion Date:
2015-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2016-06
Completion Date Type:
ESTIMATED
First Submit Date:
2014-04-04
First Submit QC Date:
None
Study First Post Date:
2014-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-06
Last Update Post Date:
2014-10-08
Last Update Post Date Type:
ESTIMATED